A Randomized, Open Labeled, Multicenter Clinical Trial on the Effectiveness and Safety of the 5-HT3-Receptor Antagonist Ramosetron in Male Patients With Irritable Bowel Syndrome With Diarrhea: Comparison With Mebeverine

✍ Scribed by Lee, Kwang Jae ;Rhee, Poong-Lyul

• Book ID: 122327295
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 93 KB
• Volume: 140
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(11)62509-2